Scribe Therapeutics Patents – Key Insights and Stats

Scribe Therapeutics has a total of 109 patents globally, out of which 3 have been granted. Of these 109 patents, more than 91% patents are active. The United States of America is where Scribe Therapeutics has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Scribe Therapeutics.

Scribe Therapeutics was founded in 2017. Scribe Therapeutics is a biotech business. The Company focuses on developing the most sophisticated CRISPR-based genetic platform. Customers are served by Scribe Therapeutics in the US.

Do read about some of the most popular patents of Scribe Therapeutics which have been covered by us in this article and also you can find Scribe Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Scribe Therapeutics patent portfolio.

How many patents does Scribe Therapeutics have?

Scribe Therapeutics has a total of 109 patents globally. These patents belong to 18 unique patent families. Out of 109 patents, 100 patents are active.

How Many Patents did Scribe Therapeutics File Every Year?

Scribe Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantScribe Therapeutics Applications FiledScribe Therapeutics Patents Granted

How many Scribe Therapeutics patents are Alive/Dead?

Worldwide Patents

Scribe Therapeutics Patent Portfolio

How Many Patents did Scribe Therapeutics File in Different Countries?

Scribe Therapeutics Worldwide Patent Filing

Countries in which Scribe Therapeutics Filed Patents

United States Of America13
Hong Kong (S.A.R.)9
South Africa3
New Zealand3
United Kingdom1
Korea (South)1

Where are Research Centers of Scribe Therapeutics Patents Located?

The Research Centers of Scribe Therapeutics Patents is the United States of America.

What Percentage of Scribe Therapeutics US Patent Applications Were Granted?

Scribe Therapeutics (Excluding its subsidiaries) has filed 7 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2 have been granted leading to a grant rate of 100%.

Below are the key stats of Scribe Therapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Scribe Therapeutics?

Law FirmTotal ApplicationsSuccess Rate
Cooley Llp7100%

What are Scribe Therapeutics key innovation segments?

What Technologies are Covered by Scribe Therapeutics?

The chart below distributes patents filed by Scribe Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Scribe Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Scribe Therapeutics search focus changed over the years?


Interested in knowing about the areas of innovation that are being protected by Scribe Therapeutics?

Leave a Comment

Table of Content

Popular Topics

Insights you may find interesting